Latest 5 articles from heartwire
- Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT - Statins benefit those at much lower CV risk
May 16, 2012 18:30 EDT - Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT - So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT - COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
Self-monitoring INR and self-managing warfarin to reduce thromboembolic events
Posted Jan 20, 2012
at 07:30 AM, EDT
by Samuel Goldhaber
A recent study published in the Lancet reports a 50% reduction in thromboembolic events among patients who self-monitor their INR and self-manage their warfarin dosing. Why aren't these practices more common?
See also:
Anticoagulation self-monitoring halves thromboembolic risk
Heneghan C, Ward A, Perera R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2011; DOI:10.1016/S0140-6736(11)61294-4. Abstract.
Previous posts
Should we prescribe novel anticoagulants or warfarin as first line agents for stroke prevention in AF?
4 Comments |
Posted May 06, 2012
at 01:25 PM, EDT by Samuel
at 01:25 PM, EDT by Samuel
Recent PE thrombolysis trials: MAPPET, MOPETT, and MUPPET, with Dr Stavros Konstantinides
No comments |
Posted Apr 27, 2012
at 11:55 AM, EDT by Samuel
at 11:55 AM, EDT by Samuel
The US Postal Service promotes heart health
No comments |
Posted Apr 20, 2012
at 01:50 PM, EDT by Samuel
at 01:50 PM, EDT by Samuel
Thrombolysis in acute pulmonary embolism: An update with Dr Stavros Konstantinides
No comments |
Posted Apr 04, 2012
at 03:08 PM, EDT by Samuel
at 03:08 PM, EDT by Samuel
Einstein PE: Rivaroxaban shines as viable monotherapy for pulmonary embolism
1 Comments |
Posted Mar 26, 2012
at 10:25 AM, EDT by Samuel
at 10:25 AM, EDT by Samuel
Also from theheart.org
Blogs I read
Who's Talking
Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA















Comments
I have Afib for over 20 years and about 4 years ago, while vacationing on Long Island, NY my INR went of the chart and I hit my back while sailing! After 3 painful nights trying to sleep I went to a doctor and he said have seen your back where one side had turned black from bleeding. He immediately gave me a shot of Vitamin K to conteract the cuamadin and I noticed he was using a Roche device to check my INR.
When I got home I contacted Roche's website and learned that patients could get their CoaguChek device through Medicare and ordered one immediately! They sent a retired nurse to my house with a new device and test strips to show me how to use it! I take my INR every 3 weeks and report the test results on their website and they fax my doctor. If it various from the prescribed 2 to 3, I adjust the dosage slightly myself and retest the following week to check the results.
I would highly recommend Afib patients taking there own INR as I have for over 3 years with great results and no problems!